PATENT CLAIM ANALYSIS

Application Number: 16240617
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "454000"]

Abstract:
A nasal spray composition and method for treating convulsive seizures, including epileptic seizures, and also autism behavioral events. In certain embodiments, the nasal spray composition contains delta-9-tetrahydrocannabinol, cannabidiol and, optionally, terpenes such as linalool.

Claim (Index 15):
The method of  claim 14  wherein the human subject is incapable of administering the composition while actively having the seizure.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15710204', '14634880', '15646342', '15449535', '15449402']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.664294190763327
- 35 USC 102 Novelty (BERT): 0.5466619082548543
- Combined Prediction Score: 0.6525309625124797
- Mean Citation Score: 199.099578
- Max Citation Score: 373.3064
- Similarity Product: 206.41466538219453

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test